Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06IVU
|
|||
| Former ID |
DNC007412
|
|||
| Drug Name |
N-(4-methylthiazol-2-yl)-2-phenylacetamide
|
|||
| Synonyms |
N-(4-methylthiazol-2-yl)-2-phenylacetamide; 91392-19-7; N-(4-methyl-1,3-thiazol-2-yl)-2-phenylacetamide; AC1LIKML; CHEMBL388116; MolPort-000-563-422; ZINC563269; AKOS001315153; MCULE-5254964555; ST50771861; N-(4-methylthiazol-2-yl)-2-phenyl-acetamide; N-(4-methyl(1,3-thiazol-2-yl))-2-phenylacetamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H12N2OS
|
|||
| Canonical SMILES |
CC1=CSC(=N1)NC(=O)CC2=CC=CC=C2
|
|||
| InChI |
1S/C12H12N2OS/c1-9-8-16-12(13-9)14-11(15)7-10-5-3-2-4-6-10/h2-6,8H,7H2,1H3,(H,13,14,15)
|
|||
| InChIKey |
YUZOFWPNYHCMMW-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | LOX-5 messenger RNA (ALOX5 mRNA) | Target Info | Inhibitor | [1] |
| BioCyc | Aspirin-triggered lipoxin biosynthesis | |||
| Resolvin D biosynthesis | ||||
| Leukotriene biosynthesis | ||||
| Lipoxin biosynthesis | ||||
| Aspirin triggered resolvin D biosynthesis | ||||
| Aspirin triggered resolvin E biosynthesis | ||||
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Serotonergic synapse | ||||
| Ovarian steroidogenesis | ||||
| Toxoplasmosis | ||||
| NetPath Pathway | IL4 Signaling Pathway | |||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Arachidonic acid metabolism | |||
| Eicosanoid Synthesis | ||||
| Selenium Micronutrient Network | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. J Med Chem. 2007 May 31;50(11):2640-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.